Abstract
Hypogammaglobulinemia (HGG) is well-characterized as a common phenomenon after kidney transplantation. However, no reports of pre-existing HGG from kidney transplantation seem to be available. We have reviewed three patients who developed HGG prior to kidney transplantation, and all three were treated successfully with immunoglobulin replacement therapy before and after kidney transplantation. The kidney grafts were functioning at follow-up 1.5-8 years (mean: 3.6 years) after transplantation, and there were no diagnosed episodes of clinical rejections and no severe infection complications post-transplantation.
Original language | English |
---|---|
Journal | Scandinavian Journal of Immunology |
Volume | 86 |
Issue number | 2 |
Pages (from-to) | 113-117 |
Number of pages | 5 |
ISSN | 0300-9475 |
DOIs | |
Publication status | Published - Aug 2017 |
Keywords
- Adult
- Agammaglobulinemia
- Female
- Graft Survival
- Humans
- Immunoglobulins
- Kidney Diseases
- Kidney Transplantation
- Male
- Middle Aged
- Preoperative Period
- Retrospective Studies
- Time Factors
- Treatment Outcome
- Case Reports
- Journal Article